Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 21.19M 19.37M 17.68M 33.31M 2.22B 34.36M 233M 93.07M 1.18B 88.68M 86.77M 3.74B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.84M 34.58M 31.56M 59.47M 3.97B 61.35M 417M 166M 2.12B 158M 155M 6.68B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 month+4.55%
3 months-34.29%
6 months-55.77%
Current year-30.30%
1 week 0
Extreme 0.0023
0
1 month 0
Extreme 0.0023
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-69.33%+43.75% 877K
-1.74%+1.20%-37.64%-57.11% 1.59B
-3.82%-6.46% - - 1.39B
+0.12%+3.21%-33.84%+37.79% 1.18B
+1.37%-12.39%-29.69%+112.82% 1.08B
+1.19%+6.37%+33.49%+46.44% 975M
+5.15%+6.49%+159.23%+622.07% 877M
-2.79%+4.09%+33.05%-28.69% 585M
-1.89%-0.32%-38.38%+12.66% 558M
+0.66%-15.62%-2.02%+83.68% 557M
Average -0.16%-3.49%+1.65%+97.05% 879.92M
Weighted average by Cap. -0.33%-2.83%+5.00%+95.02%

Financials

2015 2016
Net sales 25.48M 22.85M 20.89M 19.07M 35.92M 2.4B 37.05M 252M 100M 1.28B 95.64M 93.59M 4.03B 32.33M 29M 26.5M 24.19M 45.58M 3.04B 47.01M 319M 127M 1.62B 121M 119M 5.12B
Net income 5.49M 4.93M 4.5M 4.11M 7.75M 517M 7.99M 54.29M 21.65M 276M 20.62M 20.18M 870M 2.06M 1.85M 1.69M 1.54M 2.91M 194M 3M 20.37M 8.12M 103M 7.74M 7.57M 326M
Net Debt 24.8M 22.25M 20.33M 18.56M 34.97M 2.33B 36.07M 245M 97.72M 1.24B 93.1M 91.11M 3.93B 18.56M 16.65M 15.21M 13.89M 26.16M 1.74B 26.99M 183M 73.12M 931M 69.66M 68.17M 2.94B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock